Paolo Tarantino, MD, PhD

Paolo Tarantino, MD, PhD, is a breast medical oncologist and an advanced fellow at Dana-Farber Cancer Institute and Harvard Medical School in Boston, MA.

His clinical and research work focuses on breast cancer, with particular expertise in HER2+ disease and ADCs. Dr Tarantino’s research has contributed to the development of novel approaches to HER2 classification, ADC treatment and sequencing, and mechanisms of resistance to ADCs.

Dr Tarantino has authored more than 100 peer-reviewed publications and is actively involved in international clinical trials, translational research, and scientific education in breast oncology.